$1.82
-0.09 (-4.71%)
Array BioPharma, Inc. (ARRY)
CAPS Rating:
A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

RSS Headlines
Fool UK